Lecture 7: Pharmacokinetics Part II Flashcards
(85 cards)
what are the two phases of metabolism
phase 1 & phase 2
what is metabolism
the chemical reactions that change a drug into a compound more easily excreted or eliminated by the body
what enzymes are important for metabolism
CYP450
where does most metabolism happen
in the liver
what are the options for the product of phase I metabolism
drug metabolite w/ modified activity or inactive drug metabolite
what happens to highly lipophilic drugs
accumulation (storage in body tissues)
what happens after highly lipophilic drugs accumulate in body tissues
phase 1 metabolism (bioactivation or inactivation)
what is the produce of phase 1 metabolism
polar drug
what happens to polar drugs after undergoing phase 1 metabolism
phase 2 metabolism (inactivation)
what is the product of phase 2 metabolism
hydrophilic drug
what happens to hydrophilic products of phase 2 metabolism
excretion (renal or biliary)
what happens to lipophilic drugs
undergo phase 1 metabolism
what happens to polar drugs
undergo phase 2 metabolism
what happens to hydrophilic drugs
excreted
what chemical change happens to drugs during phase 1 metabolism
body exposes polar groups on drug
what reactions does phase 1 consist of
oxidation, reduction, or hydrolysis reactions
purpose of phase 1 reactions
convert lipophilic drugs to more polar molecules by exposing polar functional groups (like -OH or -NH2)
what enzymes do phase 1 reactions use
cytochrome P450 enzymes (CYP450)
which phase(s) do polar drugs go through
bypass phase 1 & go to phase 2 reactions
what is the superfamily of enzymes crucial for phase 1 metabolism
cytochrome P450 enzymes
what is the result of different phenotypic changes between CYP450 enzymes
people respond differently to the same drugs
which enzymes have the highest amount of allelic variants
CYP2D6, CYP2B6, and CYP2A6
what are the four types of phenotypical changes in CYPs
poor metabolizers (PM), intermediate metabolizers (IM), extensive metabolizers (EM), & ultra-rapid metabolizers (UM)
result of poor metabolizer variation
higher risk of side effects due to decreased medication clearance (higher blood levels)